Determination of intracellular tenofovir-diphosphate and emtricitabine-triphosphate concentrations in dried blood spots for pre-exposure prophylaxis adherence
- 29 February 2024
- journal article
- research article
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 30 (9) , 876-880
Abstract
No abstract availableKeywords
Funding Information
- National Center for Global Health and Medicine
- Japan International Cooperation Agency
- ViiV Healthcare
- Gilead Sciences
- Japan Health Research Promotion Bureau (2020-A-01)
This publication has 21 references indexed in Scilit:
- Real-world effectiveness of pre-exposure prophylaxis in men at high risk of HIV infection in France: a nested case-control studyThe Lancet Public Health, 2022
- Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort studyThe Lancet HIV, 2018
- Validation of an LC–MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spotsJournal of Pharmaceutical and Biomedical Analysis, 2018
- Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trialThe Lancet, 2016
- Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort studyThe Lancet Infectious Diseases, 2014
- HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trialThe Lancet Infectious Diseases, 2014
- Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC–MS/MS detectionJournal of Pharmaceutical and Biomedical Analysis, 2011
- Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis BNew England Journal of Medicine, 2008
- Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIVNew England Journal of Medicine, 2006
- Tenofovir disoproxil fumarate: A nucleotide reverse transcriptase inhibitor for the treatment of HIV infectionClinical Therapeutics, 2002